ArticleCureus2025
Use of Indocyanine Green in Fluorescence-Guided Resection of Mesenchymal Hamartoma of the Liver: A Report of Two Cases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indocyanine green (ICG) is a fluorescent agent administered preoperatively to assist in real-time visualization of pathologic tissue during a variety of surgical procedures, including the resection of solid tumors. This series describes the clinical presentation, fluorescence-guided resection, and outcome of two pediatric cases of mesenchymal hamartoma of the liver (MHL), a rare benign hepatic tumor. Use of this agent is widely documented in the literature for the management of more common malignant and benign liver tumors, though reporting for MHL is scarce. It is the purpose of this case series to contribute to the growing understanding of ICG's utility for this rare tumor, illustrated in two pediatric patients. We present the cases of a 21-month-old male patient and an 18-month-old female patient, both presenting with large hepatic masses causing symptoms secondary to compression of neighboring structures, necessitating surgical removal. Fluorescence-guided surgery using ICG was implemented for the precision resection of both neoplasms. This report provides valuable insight into ICG implementation for MHL in two pediatric patients, outlining how the agent safely and effectively facilitated the resection of these neoplasms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.